Use of taurolidine and derivatives thereof in the treatment of cancer by induction of apoptosis
CA 2696185 C · Owner: Geistlich Pharma Ag · Inventors: Darnowski, James; Calabresi, Paul
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides a method of inhibiting tumor growth in a mammal by administering to the mammal composition containing taurolidine taurultam, or a biologically active derivative thereof. The composition is administered to directly contact a tumor cell at a dose sufficient to induce cell death by apoptosis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 6, 2000 and granted September 23, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 6, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 6, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.